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Background The embolism from cardiac origin represent the second cause
by order of frequency of stroke. Among the accidents of ischemic type, 20 per
cent are related to an embolism of cardiac origin and are accessible to an
effective prevention thanks to a quick diagnosis of the heart defect. The pur-
pose of our work is to determine the epidemiological profile, clinical, para-
clinical heart disease emboligenes and assess their complex support on ground
of ischemic stroke in a hospital environment.
Methods We conducted a retrospective study of descriptive type in the car-
diology department of the hospital Ibn Rochd of Casablanca during a period
of three years (January 2012 -December 2014).
Have been included in our study all patients with this clinical manifesta-
tions suggestive of a stroke that the ischemic nature has been confirmed to the
brain scanner by a hypodensity with or without flaw. Patients had to be car-
riers of a proven heart disease high-risk of embolism as defined by the classi-
fication TOAST (Total Occlusion Angioplasty Study) and hospitalized during
these past three years in the service.
Results 102 exhibited an ischemic heart disease with high risk of embolism
giving a prevalence of 9.5 per cent or 48 men and 54 women. There was,
overall a predominantly male before 65 years and then a predominantly
female from 65 years ago. The peak occurred in the male is located between
55 and 64 years. 
The heart disease encountered are: AF (46%) on valve disease, ischemic
heart disease (27%), dilated cardiomyopathy (9%).
In the Transoesophageal Echocardiography (TEE), a spontaneous contrast
with a thrombus in the left atrial appendage in 4 cases, a dysfunction of pros-
theses in 6 cases, an infective endocarditis. The support has been carried out
on a case-by-case basis with consultation with the medical team neurological.
However, approximately 9% of the cases are complicated by haemorrhage
including 5% of deaths.
Conclusion Stroke is a major complication of heart disease. This work has
highlighted the high frequency and the role of cardiac sources of embolism
(AF; AF on mitral valve disease, mechanical valve prosthesis; the myocardial
infarction,) in the occurrence of a stroke especially Ischemic.
The association of heart disease with stroke is a public health problem in
Morocco. The support for this association requires an interdisciplinary collab-
oration (cardiologists, neurologists, radiologists) and prevention remains the
only effective measure.
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Objective Brain natriuretic peptide (BNP) quantification is a useful car-
diovascular diagnostic and prognostic test. In renal failure its use may have
constraints, as it depends on renal clearance and concomitant volume over-
load. 
The aim of this study was to evaluate the clinical usefulness of BNP in
hypertensive patients on maintenance hemodialysis (HD).
Design and Methods we measured BNP levels in 30 patients immedi-
ately before and after HD. All patients had preserved left ventricular ejec-
tion fraction (LVEF ≥50%) and underwent 48-hours ambulatory blood
pressure measurement. Cardiac parameters were evaluated by echocardio-
graphy.
Results The left ventricular mass index (LVMi) and BNP levels decreased
significantly after HD (p<0.001). LVMi was significantly associated with the
duration of hypertension (p=0.03). After HD, LVMi was significantly associ-
ated to the diurnal, nocturnal and 48-hours ambulatory blood pressure. BNP
levels were associated to diastolic blood pressure and LVMi before and after
HD. A BNP cut-off value of 68.91pg/mL after HD resulted in 81.8% speci-
ficity and 100% sensitivity for the presence of left ventricular hypertrophy
(LVH), (AUC ROC: 0.864) in hypertensive patients. 
Conclusion BNP had strong associations with prevalent LVH in hyperten-
sive patients on hemodialysis. 
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Introduction Arterial hypertension (HTN) is a major cardiovascular factor
which leads to several diseases. We hypothized that cystatin C may reflect the
cardiovascular risk in hypertensive patients.
Patients and Methods we studied 31 hypertensive patients with no exer-
tional dyspnea and 30 age and sex-matched healthy subjects. Patients didn’t
experience any history of diabetes, coronary or valvular heart disease. Kidney
and liver dysfunction were also exclusion criteria in our study. 2D and 3D
echocardiography was performed with use of speckle tracking imaging. Serum
cystatin C was also calculated. Cardiovascular risk scoring was calculated
according to the European charts (SCORE).
Results Mean patients’ age was 51±10 years. Mean left ventricular ejec-
tion fraction was similar in both hypertensive and healthy subjects (65±4
vs.64,4±4,5%, p=0,5). However, LV mass and relative wall thickness were
significantly greater in HTN group (116±19 vs. 75±18g/m2; p<0,0001 and
0,54±0,12 vs. 0,36±0,03; p<0,0001 respectively). Hypertensive patients had
greater cardiovascular risk score (1,87 vs. 0,8; p=0,009). There was higher
serum cystatin C level in HTN group (0,8±0,2 vs. 0,58±0,12mg/L;
p<0,0001). We depicted a significant positive correlation between cystatin C
levels and cardiovascular risk score (R=0,50, p<0,0001). The ROC curve
revealed that Cystatin C had a sensitivity of 82% and a specificity of 77%
to predict high cardiovascular risk with a cutoff of 0,75mg/L (AUC was
0,81; p=0,002).
Conclusion Serum cystatin C may reflect the cardiovascular risk in hyper-
tensive patients with good sensitivity and specificity. 
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